# Genetic risk of chronic pain conditions associated with risk of suicide death through an integrative analysis of EHR and genomics data

**Authors:** Seonggyun Han, Emily DiBlasi, Eric T. Monson, Andrey A. Shabalin, Lisa Baird, Danli Chen, Dirga Lamichhane, Doug Tharp, Elliott Ferris, Zhe Yu, W. Brandon Callor, Michael J. Staley, Qingqin S. Li, Virginia Willour, David K. Crockett, Karen Eilbeck, Amanda V. Bakian, Brooks R. Keeshin, Akiko Okifuji, Hilary Coon, Anna R. Docherty

PMC · DOI: 10.1038/s41398-026-03861-6 · Translational Psychiatry · 2026-02-16

## TL;DR

This study finds that genetic risk for certain chronic pain conditions is linked to a higher risk of suicide death, even when individuals are not clinically diagnosed with those pain conditions.

## Contribution

The study is the first to comprehensively assess genetic and clinical overlaps between multiple chronic pain types and suicide death using genome sequencing and electronic health records.

## Key findings

- Polygenic scores for multisite and chronic widespread pain were significantly associated with suicide mortality.
- Genetic risk for monoarticular arthritis, back pain, and chronic inflammatory demyelinating polyneuropathy also showed associations with suicide death.
- Four distinct pain-related genetic subgroups were identified among suicide death cases.

## Abstract

Chronic pain represents heritable conditions linked to suicide death. It has been suggested that a shared genetic predisposition may contribute to this relationship, but there has not yet been a comprehensive assessment of genetic and clinical overlaps of different types of chronic pain with suicide death. Here, we integrated whole-genome sequencing and electronic health records from 986 unrelated individuals of European ancestry who died by suicide in the Utah Suicide Mortality Research Study and 415 ancestrally-matched population controls selected for absence of disease. Polygenic scores (PGSs) for seven distinct types of chronic pain were calculated and tested in the suicide cohort. We observed significant positive associations of PGSs for multisite chronic pain (PGSMCP) and chronic widespread pain (PGSCWP) with suicide mortality. Sex-stratified analyses showed elevations in both males and females. Pain diagnosis-stratified analyses revealed associations with suicide death regardless of chronic pain diagnoses. Follow-up tests of PGSs for more specific pain conditions showed additional associations with suicide death for: 1) monoarticular arthritis, 2) back pain, and 3) chronic inflammatory demyelinating polyneuropathy across all suicide death individuals, and 4) irritable bowel syndrome within males only. In a multiple logistic regression test of all chronic pain PGSs associating suicide death status, four types of pain remained uniquely associated with suicide death, highlighting distinct subgroups within suicide death: some attributed to MCP and CWP, and others associated with monoarticular arthritis or chronic inflammatory demyelinating polyneuropathy. This cohort study reports associations between suicide death and PGSs from various pain conditions, regardless of sex or chronic pain diagnosis, suggesting that combining genetic and clinical risk factors may better identify genetic overlap, causal directions, and/or specific gene pathways.

## Linked entities

- **Diseases:** chronic inflammatory demyelinating polyneuropathy (MONDO:0006702), irritable bowel syndrome (MONDO:0005052)

## Full-text entities

- **Genes:** CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, CD46 (CD46 molecule) [NCBI Gene 4179] {aka AHUS2, MCP, MIC10, TLX, TRA2.10}, PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}
- **Diseases:** CIDP (MESH:D020277), PGSirritable bowel syndrome (MESH:D012778), pain condition (MESH:D013001), sleep disorders (MESH:D012893), Pain (MESH:D010146), alcohol use disorders (MESH:D000437), AD (MESH:D000544), substance use disorders (MESH:D019966), Psychiatric conditions (MESH:D001523), Cancer (MESH:D009369), polyneuropathy (MESH:D011115), IBS (MESH:D053560), anxiety (MESH:D001007), Knee pain (MESH:D046788), BD (MESH:D001528), BP (MESH:D007022), neurological disorders (MESH:D009461), IH (MESH:C565524), MDD (MESH:D003865), opioid use disorders (MESH:D009293), Monoarticular arthritis (MESH:D001168), SD (MESH:D003643), Back pain (MESH:D001416), major (MESH:D004830), SRD (MESH:C562657), NCP (MESH:D000086382), AR (MESH:D013734), Irritable bowel syndrome (MESH:D043183), Chronic Pain (MESH:D059350), depressive disorder (MESH:D003866), neuropathic pain (MESH:D009437), bipolar disorder (MESH:D001714), hyperalgesia (MESH:D006930)
- **Chemicals:** PGS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949045/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949045/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949045/full.md

---
Source: https://tomesphere.com/paper/PMC12949045